Categories Earnings, Industrials

Diana Shipping (NYSE: DSX): Q4 2019 Earnings Snapshot

— Diana Shipping Inc. (NYSE: DSX) reported a fourth-quarter 2019 loss of $0.17 per share versus a profit of $0.02 per share expected.

— Time charter revenues fell by 18% to $51.5 million versus $50.52 million expected. This was due to the sale of two vessels in December 2018 and six vessels in 2019 as well as decreased average time charter rates that it achieved for its vessels.

ship cargo container
Image for representation. Courtesy: Bernd Dittrich on Unsplash

— The average number of vessels decreased to 42.6 from 49.5 in the prior-year quarter. However, the weighted average age of vessels rose to 9.5 from 9.1 a year ago.

— Fleet utilization for the fourth quarter declined to 96.9% from 99.1% in the previous year quarter.

— Time charter equivalent rate decreased to $12,264 from $13,527 a year earlier. However, the daily vessel operating expenses rose to $5,969 from $5,536 a year ago.

— Long-term debt as of December 30, 2019, was $474.95 million while cash and cash equivalents stood at $107.29 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings

After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform

What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top